Affidea acquires a majority stake in LabPoint from Lindenhofgruppe, strengthening its diagnostics and laboratory medicine ...
Medically reviewed by Matthew Wosnitzer, MD Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also ...
DelveInsight's House Dust Mite Disease Market Insights report includes a comprehensive understanding of current treatment ...
QuantiPath, a molecular diagnostics company advancing pathogen detection and food safety innovation, today announced a ...
The house dust mite disease market is experiencing steady growth, driven by rising global prevalence of allergic rhinitis and asthma linked to indoor allergens. Increasing adoption of allergen-specifi ...
Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no OCU410-related serious ...
In a new study, researchers at Yale University performed surveillance to understand the current coronaviral landscape of wild and domestic animals in the northeastern United States. They found that ...
How HTGF combines government backing and industrial partnerships with a VC mindset to crowd in private capital and support ...
Dengue’s brutal “breakbone” fever has long been one of global health’s most stubborn failures, a disease that keeps resurging ...
Gene Solutions, a global biotechnology company, and Pangea Laboratory, a CLIA-certified, CAP-accredited Next Gener ...
Mendel’s monastery garden experiments went largely unnoticed during his life, but their implications would ripple through ...